Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9540-9540
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 506
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 87
Mitochondria in Alzheimer’s Disease Pathogenesis
Allison B. Reiss, Shelly Gulkarov, Benna Jacob, et al.
Life (2024) Vol. 14, Iss. 2, pp. 196-196
Open Access | Times Cited: 23
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 35
Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2977-2988
Open Access | Times Cited: 14
The olfactory bulb: A neuroendocrine spotlight on feeding and metabolism
Romana Stark
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 6
Open Access | Times Cited: 8
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha Shah, Kunal G. Maheshwari, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3847-3884
Closed Access | Times Cited: 16
Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 5
Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 5
Glucose metabolism impairment in major depressive disorder
Fanhao Meng, Jing Wang, Long Wang, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111191-111191
Open Access
Network Diffusion-Constrained Variational Generative Models for Investigating the Molecular Dynamics of Brain Connectomes Under Neurodegeneration
Jiajia Xie, Raghav Tandon, Cassie S. Mitchell
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1062-1062
Open Access
Trends in Alzheimer's‐Related Mortality Among Type 2 Diabetes Patients in the United States: 1999–2019
Saad Ahmed Waqas, Dua Ali, Tayyab Khan, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 2
Open Access
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Neuroprotective mitochondria targeted small molecule restores synapses and the distribution of synaptic mitochondria in the hippocampus of APP/PS1 mice
Natalie Keller, Trace Christensen, Erik J. Wanberg, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
Julius Mulumba, Rui Duan, Bo Luo, et al.
Exploration of neuroscience (2025) Vol. 4
Open Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Harnessing Animal Studies to Uncover Pyroptosis Mechanisms in Alzheimer’s Disease: A Systematic Review Protocol
Amirul Hafiz Ahmad Abdullah, Nurul Farhana Jufri, Siti Fathiah Masre, et al.
Advances in Human Biology (2025)
Open Access
Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies
Mini Dahiya, Monu Yadav, Chirag Goyal, et al.
Inflammopharmacology (2025)
Closed Access
Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model
Ylauna Christine Mégane Penalva, Sandra Paschkowsky, Jingyun Yang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer’s disease in a large clinical sample
Matthijs B de Geus, Shannon Leslie, TuKiet T. Lam, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study
Jonas Ellegaard Nielsen, Trygve Andreassen, Charlotte H. Gotfredsen, et al.
Metabolomics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Tim Bathe, Gabriela P. Hery, Jonathan A. B. Villareal, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes and TXNIP-GLUT signaling pathway
Tao Wang, Ling Hao, Kexin Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Post-Polio Syndrome Revisited
Michael Punsoni, Nelli S. Lakis, Michelle Mellion, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 569-579
Open Access | Times Cited: 10
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
Anna Atlante, Daniela Valenti
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15951-15951
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top